Means and methods for the determination of the biological activity of BoNT/E in cells Grant US-11874273-B2 United States of America 16 Jan 2024
Composition comprising recombinant clostridium neurotoxin Grant US-11642399-B2 United States of America 09 May 2023
Gangliosides for standardizing and increasing the sensitivity of cells to botulinum… Grant US-10921312-B2 United States of America 16 Feb 2021
Means and methods for the determination of the biological activity of BoNT/E in cells Grant US-10900955-B2 United States of America 26 Jan 2021
COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT Application WO-2020254690-A1 World Intellectual Property Organisation (WIPO) 24 Dec 2020
COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT Application EP-3753568-A1 European Patent Office 23 Dec 2020
Methods for the manufacture of proteolytically processed polypeptides Grant US-10808236-B2 United States of America 20 Oct 2020
Cellular test systems for the determination of the biological activities of neurotoxin… Grant US-10781421-B2 United States of America 22 Sep 2020
Methods for enhancing the specific uptake of botulinum neurotoxins into cells Grant US-10725025-B2 United States of America 28 Jul 2020
Methods for the determination of the biological activities of neurotoxin polypeptides Grant US-10634683-B2 United States of America 28 Apr 2020
Manufacture of di-chain recombinant Clostridium botulinum neurotoxins using Lys-C and a… Grant US-10307468-B2 United States of America 04 Jun 2019
Cellular test systems for the determination of the biological activities of neurotoxin… Application US-10125350-B2 United States of America 13 Nov 2018
Methods for the manufacture of proteolytically processed polypeptides Grant US-10087432-B2 United States of America 02 Oct 2018
Neurotoxins exhibiting shortened biological activity Grant US-9809809-B2 United States of America 07 Nov 2017
Compositions and methods for toxigenicity testing Grant US-9217172-B2 United States of America 22 Dec 2015
EARLY ADMINISTRATION OF BOTULINUM TOXIN IN THE TREATMENT OF CEREBROVASCULAR EVENT AND… Application WO-2009080313-A3 World Intellectual Property Organisation (WIPO) 26 May 2011
High-potency botulinum toxin formulations Application US-20100279945-A1 United States of America 04 Nov 2010
EARLY ADMINISTRATION OF BOTULINUM TOXIN IN THE TREATMENT OF CEREBROVASCULAR EVENT AND… Application WO-2009080313-A2 World Intellectual Property Organisation (WIPO) 02 Jul 2009
Early administration of Botulinum toxin in the treatment of cerebrovascular event and… Application EP-2072057-A1 European Patent Office 24 Jun 2009